**MARKET BRIEF — Thursday, February 5, 2026** **Headline: Tech & Pharma Rally on Earnings Beats, LLY Crosses $1 Trillion** **Market Overview** Following a mixed open on Wednesday, markets found direction through blockbuster earnings from key players, shaking off the previous session's tech selloff. Investors pivoted back into growth stories, with high-profile beats in the pharma and AI hardware sectors driving sentiment. **Key Movers & Data** * **Eli Lilly (LLY):** The pharma giant surged **~10%** on Wednesday, propelling its market cap past the **$1 trillion** milestone. * **Catalyst:** Q4 revenue hit **$19.3 billion** (+43% YoY), driven by soaring demand for Mounjaro ($7.4B) and Zepbound ($4.2B). * **Guidance:** The company stunned Wall Street with a bullish 2026 revenue forecast of **$80–$83 billion**, well above consensus estimates. * **Super Micro Computer (SMCI):** Shares jumped over **10%** as the AI infrastructure play signaled a return to accelerated growth. * **Performance:** Fiscal Q2 revenue reached a record **$12.7 billion**, a staggering **123% increase** year-over-year. * **Outlook:** Management raised fiscal 2026 guidance to at least **$40 billion**, citing robust demand for liquid-cooled AI server racks. **Sector Sentiment** The "bruising selloff" in software and cloud stocks earlier in the week stabilized as traders digested these results. The dual rally in **GLP-1 (weight loss)** and **AI infrastructure** confirms that capital continues to flow heavily into distinct secular growth themes, even as broader indices face volatility. **Watchlist for Today** Traders are now positioning for **Amazon’s (AMZN)** earnings report due later today, with a specific focus on AWS capacity and capital expenditure to gauge the durability of the AI spending cycle. **Next Step for You:**